Annual results
Annual Results 2010 - Jan 27, 2011
| 2010 (USD m) | 2009 (USD m) | % change (USD) | |
|---|---|---|---|
| Net sales | 50,624 | 44,267 | 14 |
| Operating income | 11,526 | 9,982 | 15 |
| Net income | 9,969 | 8,454 | 18 |
| Basic EPS (USD)1 | USD 4.28 | USD 3.70 | 16 |
| Core2 | |||
| Operating income | 14,006 | 11,437 | 22 |
| Net income | 12,029 | 10,267 | 17 |
| Basic EPS (USD) | USD 5.15 | USD 4.50 | 14 |
- 2010 average number of shares outstanding: 2 285.7 million (2009: 2 267.9 million).
- Core results for operating income, net income and earnings per share (EPS) eliminate the impact of acquisition-related factors and other significant exceptional items.
The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
